drugset / Trial / NCT00881413
Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to compare the clinical effectiveness of intravenous esomeprazole and pantoprazole in preventing recurrent bleeding in the patients with high-risk bleeding peptic ulcers after successful standard endoscopic hemostasis.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 8 mg | Intravenous |
| Subject | Esomeprazole | Small molecule | 40 mg | Intravenous |
| Comparator | Pantoprazole | Other / unclassified | 8 mg | Intravenous |
| Comparator | Pantoprazole | Other / unclassified | 40 mg | Intravenous |